News
NIH inventors have developed the first pharmacologic option for developmental stuttering, which is currently only managed by speech therapy, but addresses a $3 billion underserved global market. This technology uses small-molecule iron chelators – drugs that bind and remove excess iron – for the
There is a significant, unmet medical need for male contraceptive options. Inventors at the National Institute of Child Health and Human Development (NICHD) are seeking collaborators for a potential non-hormonal male contraceptive that could fill this need. This contraceptive works by using cyclic
There is a significant, unmet medical need for male contraceptive options. Inventors at the National Institute of Child Health and Human Development (NICHD) are seeking collaborators for a potential non-hormonal male contraceptive that could fill this need. This contraceptive works by using cyclic
Are you interested in partnering with a federal lab on vaccine technology? If so, you do not want to miss the National Cancer Institute’s Michael Salgaller speaking at the World Vaccine Congress Washington. This event will feature industry experts across the entire vaccine landscape and feature